The first overhaul of the U.S. food manufacturing process in more than 80 years, the federal Food Safety Modernization Act (FSMA) law updates the role of the government in verifying the safety and availability of our food supply. FSMA, as it rolls out, has implications for both domestic manufacturers and those that distribute goods made abroad, in foreign facilities. The Food Institute analyzed the intersection of daily food production and regulatory compliance in this first in a series of 3 presentations on FSMA.
NSF certification, Standard for dietary supplementAtul Bhombe
Manufacturers, regulators and consumers look to NSF International for the development of public health standards and certification programs that help protect the world’s food, water, consumer products and environment. NSF is a global, independent organization, our standards team facilitates development of public health standards, and our service teams test, audit and certify products and services
NSF International and its role in Dietary supplements & Nutraceutical industr...SyedArshiya4
This presentation will allow the reader to know about NSF international its history, mission, NSF Mark, role in Dietary supplements and Nutraceutical industries. It also give information on testing, inspection, certification of products.
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
NSF certification, Standard for dietary supplementAtul Bhombe
Manufacturers, regulators and consumers look to NSF International for the development of public health standards and certification programs that help protect the world’s food, water, consumer products and environment. NSF is a global, independent organization, our standards team facilitates development of public health standards, and our service teams test, audit and certify products and services
NSF International and its role in Dietary supplements & Nutraceutical industr...SyedArshiya4
This presentation will allow the reader to know about NSF international its history, mission, NSF Mark, role in Dietary supplements and Nutraceutical industries. It also give information on testing, inspection, certification of products.
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
In our post about the nutraceuticals industry, dietary supplements as a category of nutraceuticals are subject to compliance with FDA regulations under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Japan drug and cosmetics regulation.pdfBhavikaAPatel
Japan drug and cosmetics regulation
information about
organisation of PMDA
Function of PMDA
IND and NDA application
Classification of drug product
Types of Application
DMF system in Japan
Post marketing surveillance
Importing cosmetics in Japan
Herbal medicines are popular because of experience and the abundant
availability of plants in India due to its varied climatic zones. India has
around 45,000 species of plants, out of which 15,000–20,000 plants have
proven medicinal value.
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
- Nutraceutical market has shown steady increase in the last decade.
- The import, manufacture and marketing regulations for nutraceuticals in India have been streamlined with the updation of the FSSAI regulations 2016.
- RDA’s are a collection of values to express a person's nutrient need based on their life stage & gender.
- The RDA recommendations for the Indian population has been provided by the ICMR on the basis of scientific studies and subsequent data generated.
Brazil Cosmetics Regulations by ArtixioAndyThomas119
Cosmetics in Brazil are classified as Class I and Class II products based on the risk involved. In the Brazilian Market there are two ways of product authorization - registration and prior notification of a product exempted of registration.
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...Swapnil Fernandes
- European pharmaceutical legislation provides a comprehensive framework for the marketing authorisation of vaccines.
- In contrast to the European scenario, the Indian scenario for vaccines is relatively less regulated and follows the same process of approval as other biologics in spite of having a National Handbook for Vaccine Policy.
- Vaccine authorisation in the US, as is the case in EU, is a more straightforward process than in most other markets as the USFDA has provided vaccines with a distinct set of regulations in concerned areas of safety and quality.
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsDaniele Pisanello
The presentation has been used within the EIPA's Seminar "Introduction to the fundamentals of EU Food Law: principles, procedures & main regulatory components", 7 and 13 of Luly 2016, on behalf of European Commission, DG Translation.
It provides an introduction to specific legal standards relating to food additives, novel foods and food contact materials.
Biosimilars
A biosimilar is a biological medicine highly similar to another already approved biological medicine (the 'reference medicine'). (A medicine whose active substance is made by a living organism.)
Biologicals
Biological medicines contain active substances from a biological source, such as living cells or organisms and are often produced by cutting-edge technology.
Biological medicinal product
Biological Medicinal Products, also known as biologics or biologicals, are medicinal products that are manufactured using biotechnology processes and derived from living organisms or their products. They can include vaccines, blood products, gene therapies, monoclonal antibodies, recombinant proteins, and other complex biological substances.
Biological Investigational Medicinal Product
Refer to biological products that are being investigated in clinical trials or research studies to evaluate their safety, efficacy, or pharmacokinetic properties. These products have not yet received marketing authorization and are still in the experimental phase.
In the European Union, A biological substance is referred as the active ingredient in biological products.
A "biological substance" is defined as "a substance that is produced by or extracted from a biological source
That requires a combination of physico-chemical-biological testing, along with the production process and its control, for its characterization and the determination of its quality.“
Examples: Immunologic medicines
Medicines derived from human blood and plasma
Medicines developed by means of recombinant DNA technology
Hybridoma and mAb methods
Advanced therapy medicinal products
The requirements of the EU centralized procedure.
The approval standards for biotechnology products are the same as for chemically synthesized medicines.
Both types of products must be safe and effective and have appropriate quality.
MAA for a biotechnology product must meet the standard dossier submission requirements
MAA must generally comply with the CTD format, including with respect to
Module I (administrative information, including labelling)
Module 2 (various summaries)
Module 3 (chemical, pharmaceutical, and biological information)
Module 4 (nonclinical reports)
Module 5 (clinical study reports)
The EU has approved the highest number of biosimilars worldwide, and consequently has the most extensive experience of their use and safety.
EMA has issued scientific guidelines to help developers conform to the strict regulatory requirements for approving biosimilars.
The guidelines have evolved to keep pace with rapid advances in biotechnology and analytical sciences, and they take on board increasing experience of clinical use.
All medicines produced using biotechnology and those for specific indications must be approved in the EU through EMA
Some biosimilars may be approved at national level, such as some low-molecular weight heparins derived from porcine intestinal mucosa.
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
Food Safety Modernization Act: for importersLina Bush
The Food Safety Modernization Act is the largest overhaul of the U.S. food processing system in more than 80 years. Thought it impacts domestic and foreign producers, there are quite a few changes in the new law important for Importers & foreign food manufacturers. Here is a highlight on how FSMA impacts Imported foods.
The recently enacted Food Safety Modernization Act is the greatest expansion of FDA’s food regulatory authority since the enactment in 1938 of the Federal Food, Drug, and Cosmetic Act. This presentation discuses the scope, impact and implementation of the Act. Presented by FDAImports.com Founder and CEO, Benjamin England.
For more on the Food Safety Modernization Act and how it affects companies, manufacturers and importers please visit:
http://www.fdaimports.com/FSMA
In our post about the nutraceuticals industry, dietary supplements as a category of nutraceuticals are subject to compliance with FDA regulations under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Japan drug and cosmetics regulation.pdfBhavikaAPatel
Japan drug and cosmetics regulation
information about
organisation of PMDA
Function of PMDA
IND and NDA application
Classification of drug product
Types of Application
DMF system in Japan
Post marketing surveillance
Importing cosmetics in Japan
Herbal medicines are popular because of experience and the abundant
availability of plants in India due to its varied climatic zones. India has
around 45,000 species of plants, out of which 15,000–20,000 plants have
proven medicinal value.
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
- Nutraceutical market has shown steady increase in the last decade.
- The import, manufacture and marketing regulations for nutraceuticals in India have been streamlined with the updation of the FSSAI regulations 2016.
- RDA’s are a collection of values to express a person's nutrient need based on their life stage & gender.
- The RDA recommendations for the Indian population has been provided by the ICMR on the basis of scientific studies and subsequent data generated.
Brazil Cosmetics Regulations by ArtixioAndyThomas119
Cosmetics in Brazil are classified as Class I and Class II products based on the risk involved. In the Brazilian Market there are two ways of product authorization - registration and prior notification of a product exempted of registration.
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...Swapnil Fernandes
- European pharmaceutical legislation provides a comprehensive framework for the marketing authorisation of vaccines.
- In contrast to the European scenario, the Indian scenario for vaccines is relatively less regulated and follows the same process of approval as other biologics in spite of having a National Handbook for Vaccine Policy.
- Vaccine authorisation in the US, as is the case in EU, is a more straightforward process than in most other markets as the USFDA has provided vaccines with a distinct set of regulations in concerned areas of safety and quality.
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsDaniele Pisanello
The presentation has been used within the EIPA's Seminar "Introduction to the fundamentals of EU Food Law: principles, procedures & main regulatory components", 7 and 13 of Luly 2016, on behalf of European Commission, DG Translation.
It provides an introduction to specific legal standards relating to food additives, novel foods and food contact materials.
Biosimilars
A biosimilar is a biological medicine highly similar to another already approved biological medicine (the 'reference medicine'). (A medicine whose active substance is made by a living organism.)
Biologicals
Biological medicines contain active substances from a biological source, such as living cells or organisms and are often produced by cutting-edge technology.
Biological medicinal product
Biological Medicinal Products, also known as biologics or biologicals, are medicinal products that are manufactured using biotechnology processes and derived from living organisms or their products. They can include vaccines, blood products, gene therapies, monoclonal antibodies, recombinant proteins, and other complex biological substances.
Biological Investigational Medicinal Product
Refer to biological products that are being investigated in clinical trials or research studies to evaluate their safety, efficacy, or pharmacokinetic properties. These products have not yet received marketing authorization and are still in the experimental phase.
In the European Union, A biological substance is referred as the active ingredient in biological products.
A "biological substance" is defined as "a substance that is produced by or extracted from a biological source
That requires a combination of physico-chemical-biological testing, along with the production process and its control, for its characterization and the determination of its quality.“
Examples: Immunologic medicines
Medicines derived from human blood and plasma
Medicines developed by means of recombinant DNA technology
Hybridoma and mAb methods
Advanced therapy medicinal products
The requirements of the EU centralized procedure.
The approval standards for biotechnology products are the same as for chemically synthesized medicines.
Both types of products must be safe and effective and have appropriate quality.
MAA for a biotechnology product must meet the standard dossier submission requirements
MAA must generally comply with the CTD format, including with respect to
Module I (administrative information, including labelling)
Module 2 (various summaries)
Module 3 (chemical, pharmaceutical, and biological information)
Module 4 (nonclinical reports)
Module 5 (clinical study reports)
The EU has approved the highest number of biosimilars worldwide, and consequently has the most extensive experience of their use and safety.
EMA has issued scientific guidelines to help developers conform to the strict regulatory requirements for approving biosimilars.
The guidelines have evolved to keep pace with rapid advances in biotechnology and analytical sciences, and they take on board increasing experience of clinical use.
All medicines produced using biotechnology and those for specific indications must be approved in the EU through EMA
Some biosimilars may be approved at national level, such as some low-molecular weight heparins derived from porcine intestinal mucosa.
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
Food Safety Modernization Act: for importersLina Bush
The Food Safety Modernization Act is the largest overhaul of the U.S. food processing system in more than 80 years. Thought it impacts domestic and foreign producers, there are quite a few changes in the new law important for Importers & foreign food manufacturers. Here is a highlight on how FSMA impacts Imported foods.
The recently enacted Food Safety Modernization Act is the greatest expansion of FDA’s food regulatory authority since the enactment in 1938 of the Federal Food, Drug, and Cosmetic Act. This presentation discuses the scope, impact and implementation of the Act. Presented by FDAImports.com Founder and CEO, Benjamin England.
For more on the Food Safety Modernization Act and how it affects companies, manufacturers and importers please visit:
http://www.fdaimports.com/FSMA
2011 GMA Conference: A Bit(e) of HistoryBill Marler
Food safety attorney Bill Marler's presentation at the 2011 Grocery Manufacturers Association Foodborne Illness Litigation Conference in Chicago in which he reviews the history of foodborne illness policy in the United States and how the culmination of numerous factors ultimately lead to the passage of The Food Safety Modernization Act in 2010.
U.S. FDA Food Safety Modernization Act (FSMA) Seminar (English)Registrar Corp
The U.S. Food and Drug Administration (FDA) Food Safety Modernization Act (FSMA) presents many important changes for companies exporting food to the United States.
Food Safety Modernization Act: What Does It Mean For Importers?AudioEducator
Learn the new regulations for food safety import. Understand how FSMA requires importers to conduct risk-based preventive controls and verification activities.
Under Food Safety modernization Act (FSMA) Food and Drug Administration (FDA) issued final rule for Foreign Supplier Verification Programs (FSVP) on November 13, 2015
Foreign Supplier Verification Programs (FSVP) applies to all imported food, beverages, and dietary supplements/ingredients unless the importer or foreign supplier is exempted by FSMA, or it the food is under the exclusive jurisdiction of USDA.
FSVP Rule requires importers to share responsibility for ensuring safety of imported product!
“Importer” is U.S. owner or consignee of a food at time of U.S. entry.
If no U.S. owner or consignee at entry, importer is U.S. agent or representative of the foreign owner or consignee, as confirmed in signed statement of consent.
A webinar presented by the Food & Beverage Industry Alliance, covering the legal, IT and business perspectives of the FDA's Food Safety Modernization Act
The Food Safety Modernization Act (FSMA) includes changes related to sanitary transportation that will affect retailers and wholesalers with distribution centers; and retailers and wholesalers with distribution centers and truck fleets. This is the first time FDA has proposed comprehensive rules related to transportation so the proposed changes impose significant new requirements for food retailers.
For example, FDA includes requirements related to the design and maintenance of vehicles and transportation equipment to ensure that it does not cause the food that it transports to become contaminated. (Reference: Stephanie Barnes, Regulatory Counsel, Food Marketing Institute)
Are you ready to implement FDA Food Safety Modernization Act?Nikoo Arasteh
Food Modernization Act was signed into law on January 5th 2011. Related regulations are being written and will be enforced piece by piece. Companies will have between 2 to 4 years to complete implementation of required safety systems based on their operation size. This presentation shows what FSMA is about, who will be impacted and what the deadlines are for compliance.
2016 Business of Farming Conference: FDA Food Safety Modernization Act Produc...asapconnections
The New FDA Food Safety Modernization Act (FSMA) Produce Rule: How Will It Affect Your Farm?
The 2011 Food Safety Modernization Act is the largest overhaul of the food system since 1938, and includes new regulations as of November 2015 for produce farms and facilities that process food. Your business may be affected if you operate a farm that grows and sells fresh produce and/or processes, packs, manufactures, or holds food. This session will provide farmers and agriculture support personnel an overview of the FSMA Produce Safety Rule. By the end of the session, you will learn the extent to which this FDA regulation will cover your farm operations and what key requirements need to be followed in order to be compliant.
Chris Reedy of NC BioNetwork
Preparing for New FSMA Preventive Controls RegulationsAlchemy Systems
FDA's current deadline for publishing the final rules for preventative controls for is quickly approaching. Find out what your company needs to know to prepare for these new regulatory requirements for FDA-regulated processors. This presentation provides an overview of preventative controls requirements under the Food Safety Modernization Act (FSMA), what is HARPC, and how to make the HACCP to HARPC conversion, as well as reassessing food safety plans for compliance and effectiveness.
Losses due non-compliance with China food regulation and how to overcome Chi...Rong Liu
As the world’s largest imported food market, China imported totally 38 billion US dollars food products from187 countries in 2016.
The growing China market has attracted a lot of interest from different countries over the world. Meanwhile China government has, over the last years, developed a tougher and tougher food regulation regime to regulate the market and ensure food safety.
Due to various challenges (languages, resources, information accessibility etc.), foreign SMEs learned a lot lessons and experienced big losses due to non-compliance with Chinese regulations.
Actually majority of these losses due non-compliance can be easily prevented if SMEs have reliable regulatory information in hand.
As a leading Chinese food regulation consulting company, FoodMate developed “Compliance Excellence” information service product for foreign SMEs with target to minimize your losses due regulatory non-compliance by assessing reliable and tailor made regulatory information.
FoodMate “Compliance Excellence” to reduce your losses due non-compliance wit...Rong Liu
As the world’s largest imported food market, China imported totally 38 billion US dollars food products from187 countries in 2016.
The growing China market has attracted a lot of interest from different countries over the world. Meanwhile China government has, over the last years, developed a tougher and tougher food regulation regime to regulate the market and ensure food safety.
Due to various challenges (languages, resources, information accessibility etc.), foreign SMEs learned a lot lessons and experienced big losses due to non-compliance with Chinese regulations.
Actually majority of these losses due non-compliance can be easily prevented if SMEs have reliable regulatory information in hand.
As a leading Chinese food regulation consulting company, FoodMate developed “Compliance Excellence” information service product for foreign SMEs with target to minimize your losses due regulatory non-compliance by assessing reliable and tailor made regulatory information.
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016TGA Australia
Firsthand overview of the TGA's Pharmacovigilance Inspection programme from the perspective of both the TGA and companies that have participated in the 'Pilot Inspection Programme'.
Presentation: Spotlight on prescription medicines reformsTGA Australia
An overview of initiatives arising from the Review of Medicines and Medical Devices Regulation relevant to prescription medicines as well as orphan drugs and developments for eCTD and the new MedSearch app.
TGA presentation: Provisional approval pathway for prescription medicinesTGA Australia
This presentation provided an overview of some of the reform activities relevant to prescription, OTC and complementary medicines and implementation of recommendations from the Review of Medicines and Medical Devices Regulation including the content of the consultations on enhancements
Overview of FDA Drug Manufacturing RequirementsMichael Swit
Presentation on FDA Regulation of Drug Manufacturing to the Introduction to Drug Law Course sponsored by the Food & Drug Law Institute (FDLI) on July 25, 2018 in San Francisco.
Review of key considerations in managing relationships between the sponsor of clinical study and the clinical investigator, including issues such as budget, GCP compliance, and what can go wrong if FDA takes enforcement action.
This powerpoint presentation includes all the details regarding the topic Drug approval process with special procedure of Drug approval process in India.
Similar to U.S. Food Safety Modernization Act: A Primer (20)
Food Processing and Preservation Presentation.pptxdengejnr13
The presentation covers key areas on food processing and preservation highlighting the traditional methods and the current, modern methods applicable worldwide for both small and large scale.
Vietnam Mushroom Market Growth, Demand and Challenges of the Key Industry Pla...IMARC Group
The Vietnam mushroom market size is projected to exhibit a growth rate (CAGR) of 6.52% during 2024-2032.
More Info:- https://www.imarcgroup.com/vietnam-mushroom-market
Hotel management involves overseeing all aspects of a hotel's operations to ensure smooth functioning and exceptional guest experiences. This multifaceted role includes tasks such as managing staff, handling reservations, maintaining facilities, overseeing finances, and implementing marketing strategies to attract guests. Effective hotel management requires strong leadership, communication, organizational, and problem-solving skills to navigate the complexities of the hospitality industry and ensure guest satisfaction while maximizing profitability.
4. for key information
to access it all!
The Food Institute strives to
be the best single source for
reliable food business
insight, from farm to fork.
We deliver this in multiple
ways for members to tap in
how and when they choose.
6. Enacted January 4, 2011
Most expansive changes since 1938 Act
Sweeping new enforcement authorities
Exacting new food import requirements
Major new program activities for FDA
Ambitious schedule for increased
inspections
*
8. Must re-register every even-numbered year
(Oct. 1 – Dec. 31)
New registration information
Introducing food into commerce without
complying is a “prohibited act”
*
10. FDA is required to conduct vulnerability
assessment of food system and determine
mitigation strategies to protect against
intentional adulteration
Implementation:
FDA regulations within 18 months
FDA guidance documents within 1 year
*
11. Hazard analysis and preventive controls
plan
Registered food facilities must keep hazard
analysis and preventive controls plan and
related records for 2 years
*
12. Domestic high-risk facilities: every 3 years
Other domestic facilities: every 5 years
When: effective immediately, but subject to
appropriations
*
13. If foreign facility, or
government of a foreign
country, refuses to permit
entry of U.S. inspectors or
designees within 24 hours of
official request, food from
that facility will be refused
admission
*
14. No registration fee
Fee for each facility subject to re-inspection
Fee for failure to comply with a recall order
Fee for accredited third-party auditors
Fee for export certificates
*
16. FDA has discretionary authority to require
consumer notification of “reportable foods”
If report made to the Reportable Food Registry,
FDA may require responsible party to submit
“consumer-oriented information” to FDA
FDA then will post 1-page summary on its
website
*
17. Any grocery store that sold
reportable food and is part of chain
with 15 or more locations must
provide notification to consumers
within 24 hours and maintain for 14
days
Manner and location of notification
to be determined by FDA within 1
year (e.g., notice where food is sold
in store, targeted information given
to consumer at cash register)
Question: What is a grocery store?
*
18. All testing of food for a
regulatory purpose must be done
by an accredited lab and results
sent directly to FDA
Regulatory testing:
for admission of imported food,
removal from Import Alert,
to comply with a specific testing
requirement, or
otherwise required by FDA
When: within 30 months
*
20. FDA must first give company opportunity to
voluntarily recall product
If no voluntary recall, FDA may order
company to cease distribution
After opportunity for informal hearing
(within 2 days), FDA may order recall.
Failure to comply a is “prohibited act” and
subject to civil fine ($50,000 for
individuals, $250,000 for companies)
*
21. FDA may detain food if “reason
to believe” article of food is
adulterated or misbranded
Previously, FDA needed “credible
evidence” food posed “threat of
serious adverse health
consequences or death”
When: within 180 days
*
22. If reasonable probability food from
a facility will cause serious adverse
health consequences or death to
humans or animals, FDA may
suspend registration of:
Facility responsible for causing hazard;
and
Any facility that packed, received, or
held the food if it knew, or had reason
to know, of hazard
When: within 180 days
Implementation: FDA to issue
regulations
*
23. The FSMA greatly expands FDA
records access authority
Hazard analysis and preventive
controls plan and certain related
records (e.g., monitoring records,
verification records,
nonconformance and corrective
action records)
*
24. Reports of regulatory audits
by accredited third-party
auditors and documents used
to prepare such reports
*
27. Registration fees
Civil fines (except for failure to comply
with recall order)
Country of origin labeling
Full pedigree traceability
Reportable Food Registry reporting
requirement extended to all employees
*
28. FDA has 6 Working Groups in charge of
implementation:
Preventive Standards
Inspection and Compliance
Imports
Federal-State Integration
Fees
Reports and Studies
*
29. “We recognize that third-party
inspection programs need to be a
bigger part of the discussion because
we can’t do all the work ourselves.”
John Taylor, Acting Principal Deputy
Commissioner, FDA (quoted in
Bloomberg Businessweek)
*
30. Improve documentation/recordkeeping
Hazard analysis and preventive controls plan
USDA National Agricultural Library, Food
Safety Information Center:
http://fsrio.nal.usda.gov/nal_display/index.php?
info_center=1&tax_level=1&tax_subject=614
The Food Institute’s resource on HACCP
https://foodinstitute.com/catalog/product/haac
p-us-food-safety-2nd-ed
Foreign Supplier Verification Program
Domestic facilities should also review
supply chain management
*
31. 31
*
*FDA’s webpage on the FSMA:
http://www.fda.gov/Food/FoodSafety/FSMA/default.htm
*The Food Institute’s webinar series on FSMA
implementation for companies:
https://foodinstitute.com/catalog/product/Food-Safety-
Modernization-Act-series
*Washington Section of www.FoodInstitute.Com & Weekly
Report
32. Brian Todd
The Food Institute
201-791-5570
Brian.Todd@FoodInstitute.com
*THANK YOU
www.foodinstitute.com/joinfi
Editor's Notes
Increased inspection frequency
Expanded records access
Import certification authority
Mandatory recall authority
Fees
Port shopping
Whistleblower protection
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
Domestic high-risk facilities
At least once in the next five years
At least once every three years thereafter
Domestic low-risk facilities
At least once in the next seven years
At least once every five years thereafter
Foreign facilities
600 facilities in 2011
Twice as many as the previous year for the next five years
FDA is thinking about ways to leverage foreign government inspections.
FDA already requires foreign government certification for certain imported foods under MOUs.
FDA has MOUs with Mexico for certification of cantaloupe, and with China for certification of several foods including farm-raised fish. We expect to see more of these.